Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-28 4:28 pm Sale | 13G | RayzeBio Inc. RYZB | VIKING GLOBAL INVESTORS LP | 0 0.000% | -6,642,700 (Position Closed) | View |
| 2024-02-14 8:44 pm Purchase | 13G | RayzeBio Inc. RYZB | Venrock Healthcare Capital Partners III L.P. | 4,030,471 6.700% | 13,624 (+0.34%) | View |
| 2024-02-09 4:38 pm Purchase | 13G | RayzeBio Inc. RYZB | venBio Global Strategic Fund III L.P. | 5,158,162 8.500% | 5,158,162 (New Position) | View |
| 2024-02-08 6:24 pm Purchase | 13G | RayzeBio Inc. RYZB | Versant Venture Capital VII L.P. | 4,565,015 7.600% | 4,565,015 (New Position) | View |
| 2024-02-08 10:17 am Purchase | 13G | RayzeBio Inc. RYZB | WELLINGTON MANAGEMENT GROUP LLP | 3,504,409 5.740% | 3,504,409 (New Position) | View |
| 2023-09-29 4:15 pm Purchase | 13G | RayzeBio Inc. RYZB | Venrock Healthcare Capital Partners III L.P. | 4,016,847 6.600% | 4,016,847 (New Position) | View |
| 2023-09-21 5:10 pm Purchase | 13G | RayzeBio Inc. RYZB | VIKING GLOBAL INVESTORS LP | 6,642,700 10.900% | 6,642,700 (New Position) | View |